Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
2 pending office actions • 1 art units • 1 examiners • 0 of 2 (0%) have an AI response strategy ready
Rprd Diagnostics LLC maintains a focused presence in the Biotechnology & Pharmaceuticals technology area with 2 pending office actions currently active. Unlike portfolios with distributed workloads, this entire set of 2 pending office actions is assigned to 1 distinct examiner. This creates a centralized prosecution environment where a single individual at the USPTO evaluates the company's current patent applications.
The 1 distinct examiner involved is CASH, KAILEY ELIZABETH, who serves as the busiest examiner with 2 pending office actions under her review. Furthermore, these proceedings are contained within 1 distinct art unit. This high level of concentration means that the legal strategy for Rprd Diagnostics LLC is currently dependent on the interpretations and requirements of a single examiner and a single technical group within the Biotechnology & Pharmaceuticals field.
Practitioners should recognize that having 2 pending office actions with CASH, KAILEY ELIZABETH allows for a highly consistent dialogue. Because there is only 1 distinct art unit involved, the technical arguments used in one case are likely to be directly relevant to the other. This structure simplifies the management of the 2 pending office actions by eliminating the need to reconcile different examiner styles or art unit standards, ensuring a unified prosecution path.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (50%) |
| Double-patenting + other | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| CASH, KAILEY ELIZABETH | 2 | 28.6% | +64.3% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18554174 | METHODS AND SYSTEMS FOR ANALYZING COMPLEX GENOMIC REGIONS | CASH, KAILEY ELIZABETH | 82d |
| 17766946 | METHODS AND SYSTEMS FOR ANALYZING COMPLEX GENOMIC REGIONS | CASH, KAILEY ELIZABETH | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18554174 | METHODS AND SYSTEMS FOR ANALYZING COMPLEX GENOMIC REGIONS | CASH, KAILEY ELIZABETH | 82d |
| 17766946 | METHODS AND SYSTEMS FOR ANALYZING COMPLEX GENOMIC REGIONS | CASH, KAILEY ELIZABETH | — |
| Art Unit | Apps |
|---|---|
| 1683 | 2 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18554174 | METHODS AND SYSTEMS FOR ANALYZING COMPLEX GENOMIC REGIONS | CASH, KAILEY ELIZABETH | 1683 | §103§112DP | Non-Final OA | 82d | Pending | Oct 05, 2023 |
| 17766946 | METHODS AND SYSTEMS FOR ANALYZING COMPLEX GENOMIC REGIONS | CASH, KAILEY ELIZABETH | 1683 | §103Other | Non-Final OA | — | Pending | Apr 06, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial